Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Local Institution - 0011 Birmingham, Alabama, United States
  • University of California, Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

NCT06282159

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Irvine, California, United States
  • Clinical Study Site Stamford, Connecticut, United States
  • Clinical Study Site Boca Raton, Florida, United States
View all 56 locations
View Trial Details
Active, not recruiting

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

NCT06436742

Conditions
CMS, Congenital Myasthenic Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
Locations
  • UC Davis Medical Center Sacramento, California, United States
  • Ann and Robert H Lurie Childrens Hospital of Chicago Chicago, Illinois, United States
  • Ottawa Hospital Research Institute - Civic Campus Ottawa, Canada
  • CHU - Hospital de la Timone Marseille, France
View Trial Details
Active, not recruiting

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

NCT05070858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology 2018 Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • University of Southern California Los Angeles, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
View all 116 locations
View Trial Details
Active, not recruiting

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

NCT06558279

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • Loma Linda University Health Loma Linda, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 102 locations
View Trial Details
Active, not recruiting

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

NCT05556096

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Orange, California, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Bradenton, Florida, United States
View all 132 locations
View Trial Details
Active, not recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

NCT06106672

Conditions
AChR Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Infusion for Health Brea, California, United States
  • University of California, Irvine Orange, California, United States
  • University of California, Davis Sacramento, California, United States
View all 17 locations
View Trial Details
Active, not recruiting

Myasthenia Gravis Inebilizumab Trial

NCT04524273

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Viela Bio Investigative Site - 1015 Orange, California, United States
  • Viela Bio Investigative Site - 1002 New Haven, Connecticut, United States
  • Viela Bio Investigative Center - 1024 Washington D.C., District of Columbia, United States
  • Viela Bio Investigative Site - 1005 Tampa, Florida, United States
View all 104 locations
View Trial Details

Related conditions